Noresmea (Norethisterone Acetate, Estradiol)

Noresmea is a combined hormonal contraceptive that acts on the reproductive endocrine pathway to prevent pregnancy.

• Contraception: Prevents pregnancy by inhibiting ovulation and modifying cervical mucus.
• Menstrual cycle regulation: Helps achieve more regular menstrual bleeding patterns.
• Acne improvement: May reduce acne associated with androgen excess in women.

• Norethisterone acetate acts as a progestogenic agent that suppresses the hypothalamic‑pituitary‑ovarian axis, preventing the mid‑cycle luteinizing hormone surge and thus ovulation. Estradiol provides estrogenic activity that stabilises the endometrium and enhances the contraceptive effect while also influencing cervical mucus viscosity.

Common Side Effects

• Nausea: mild to moderate stomach upset.
• Breast tenderness: discomfort or swelling of the breasts.
• Headache: occasional tension‑type headaches.
• Weight gain: slight increase in body weight.
• Mood changes: irritability or mood swings.
• Breakthrough bleeding: spotting between periods.

Serious or Rare Side Effects

• Venous thromboembolism: deep vein thrombosis or pulmonary embolism.
• Arterial thrombosis: stroke or myocardial infarction.
• Hypertension: elevated blood pressure.
• Liver tumor: benign hepatic adenoma.
• Gallbladder disease: cholelithiasis or cholecystitis.
• Severe allergic reaction: anaphylaxis or angioedema.

Before initiating therapy, consider the following precautions.

• Thrombotic risk assessment: evaluate personal and family history of clotting disorders.
• Smoking restriction: avoid smoking if over 35 years of age.
• Liver function: review hepatic disease or abnormal liver enzymes.
• Blood pressure monitoring: check for hypertension before and during treatment.
• Missed dose guidance: advise patients on steps to take after a missed tablet.
• Store at ambient temperature: keep below 25 °C in the original packaging, protect from moisture.

Drug interactions may alter the effectiveness of Noresmea.

Major Interactions (Avoid)

• Rifampin and other strong enzyme inducers: reduce contraceptive efficacy.
• Carbamazepine: may decrease hormone levels.
• St. John's wort: can lower plasma concentrations.
• Protease inhibitors (e.g., ritonavir): may affect hormone metabolism.
• Other estrogen‑containing products: increase risk of estrogen‑related adverse events.

Moderate Interactions (Monitor Closely)

• Ketoconazole and other azole antifungals: may increase hormone levels.
• Macrolide antibiotics (e.g., erythromycin): potential modest reduction in efficacy.
• Selective serotonin reuptake inhibitors: monitor for mood changes.
• Antihypertensives: watch for additive blood pressure effects.
• Herbal supplements (e.g., ginseng): assess for possible interaction.